LigaChem Biosciences to issue CBs
리가켐바이오
141080
Signal Score
Historical Avg Return (5d)
+0.31%
Data Coverage
100%n=2386
Risk-adjusted indicator based on 2386 historical DART filings. For informational purposes only — not investment advice.
Financial Impact
NEGATIVE
Key Numbers
- • Call Option: Up to 10% of CBs every 3 months from 24 to 48 months post-issuance
- • Call Option Price: Issuance amount + 1% annual compound interest from issuance date
- • Conversion Price Adjustment Dates: Annually from July 24, 2027, to July 24, 2035
AI Analysis Summary
LigaChem Biosciences Inc. has decided to issue convertible bonds (CBs). The report details the terms of the CBs, including a call option allowing the company or a designated third party to repurchase up to 10% of the CBs every three months, starting 24 months after issuance and continuing until 48 months. The repurchase price will be the issuance amount plus 1% annual compound interest. Conversion price adjustments are scheduled annually from July 24, 2027, to July 24, 2035. The specific total amount, conversion price, and number of shares to be issued upon conversion are not yet disclosed, pending further announcement. This issuance could lead to potential dilution for existing shareholders.
Track Korean Market Signals — Free
Sign up free to access live disclosures, AI analysis, and event filters.
Public Beta · No credit card required
This content is for informational purposes only and does not constitute investment advice. Past signal patterns do not guarantee future results. All data is sourced from public DART filings.